Daniel R. Vlock
CEO
Department of Pharmaceuticals
Cognoptix
United States of America
Biography
Dr. Vlock brings extensive pharmaceutical industry and academic experience in pharmaceutical drug development. Dr. Vlock is founder and CEO of Alopexx Pharmaceuticals which is developing a fully human monoclonal antibody directed against S. aureus. He has also held senior-level medical and research positions at GPC Biotech, Inc., Pharmacia Corporation, Ethicon Endo-Surgery (a subsidiary of Johnson & Johnson Company), and Boehringer Ingelheim Pharmaceuticals, Inc., where he was involved in the development of numerous oncology drugs, medical devices and drug-device combinations.
Research Interest
Pharmaceuticals
